WO2002032377A3 - Estrogen receptor modulators - Google Patents
Estrogen receptor modulators Download PDFInfo
- Publication number
- WO2002032377A3 WO2002032377A3 PCT/US2001/042735 US0142735W WO0232377A3 WO 2002032377 A3 WO2002032377 A3 WO 2002032377A3 US 0142735 W US0142735 W US 0142735W WO 0232377 A3 WO0232377 A3 WO 0232377A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- estrogen
- receptor modulators
- compounds
- estrogen receptor
- functioning
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
- C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
- C07D327/06—Six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
- C07D339/08—Six-membered rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Priority Applications (19)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL15498401A IL154984A0 (en) | 2000-10-19 | 2001-10-15 | Estrogen receptor modulators |
JP2002535616A JP2004511502A (en) | 2000-10-19 | 2001-10-15 | Estrogen receptor modulator |
PL01361053A PL361053A1 (en) | 2000-10-19 | 2001-10-15 | Estrogen receptor modulators |
KR10-2003-7005518A KR20030042020A (en) | 2000-10-19 | 2001-10-15 | Estrogen receptor modulators |
AU3238102A AU3238102A (en) | 2000-10-19 | 2001-10-15 | Estrogen receptor modulators |
SK477-2003A SK4772003A3 (en) | 2000-10-19 | 2001-10-15 | Estrogen receptor modulators |
EP01987654A EP1333827A2 (en) | 2000-10-19 | 2001-10-15 | Estrogen receptor modulators |
EA200300474A EA200300474A1 (en) | 2000-10-19 | 2001-10-15 | ESTROGEN RECEPTOR MODULATORS |
CA002424729A CA2424729A1 (en) | 2000-10-19 | 2001-10-15 | Estrogen receptor modulators |
BR0114689-0A BR0114689A (en) | 2000-10-19 | 2001-10-15 | Compound, pharmaceutical composition, process for producing a pharmaceutical composition, methods for eliciting an estrogen receptor modulation effect in a mammal, for the treatment or prevention of osteoporosis, postmenopause in a female, and for the treatment or prevention of a disorder |
AU2002232381A AU2002232381B2 (en) | 2000-10-19 | 2001-10-15 | Estrogen receptor modulators |
EEP200300153A EE200300153A (en) | 2000-10-19 | 2001-10-15 | Estrogen Receptor Modulators, Pharmaceutical Composition and Method of Preparation |
HU0303563A HUP0303563A2 (en) | 2000-10-19 | 2001-10-15 | Estrogen receptor modulators |
MXPA03003485A MXPA03003485A (en) | 2000-10-19 | 2001-10-15 | Estrogen receptor modulators. |
US10/120,723 US6750213B2 (en) | 2000-10-19 | 2002-04-11 | Estrogen receptor modulators |
PE2002000308A PE20021083A1 (en) | 2000-10-19 | 2002-04-15 | MODULATORS OF THE ESTROGEN RECEPTORS |
BG107676A BG107676A (en) | 2000-10-19 | 2003-03-26 | Estrogen receptor modulators |
IS6761A IS6761A (en) | 2000-10-19 | 2003-03-27 | Estrogen receptor regulators |
NO20031737A NO20031737L (en) | 2000-10-19 | 2003-04-15 | estrogen |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24158200P | 2000-10-19 | 2000-10-19 | |
US60/241,582 | 2000-10-19 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/120,723 Continuation-In-Part US6750213B2 (en) | 2000-10-19 | 2002-04-11 | Estrogen receptor modulators |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002032377A2 WO2002032377A2 (en) | 2002-04-25 |
WO2002032377A3 true WO2002032377A3 (en) | 2002-08-22 |
Family
ID=22911282
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/042735 WO2002032377A2 (en) | 2000-10-19 | 2001-10-15 | Estrogen receptor modulators |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1333827A2 (en) |
JP (1) | JP2004511502A (en) |
KR (1) | KR20030042020A (en) |
CN (1) | CN1469743A (en) |
AU (2) | AU2002232381B2 (en) |
BG (1) | BG107676A (en) |
BR (1) | BR0114689A (en) |
CA (1) | CA2424729A1 (en) |
EA (1) | EA200300474A1 (en) |
EC (1) | ECSP034558A (en) |
EE (1) | EE200300153A (en) |
HU (1) | HUP0303563A2 (en) |
IL (1) | IL154984A0 (en) |
IS (1) | IS6761A (en) |
MX (1) | MXPA03003485A (en) |
NO (1) | NO20031737L (en) |
PE (1) | PE20021083A1 (en) |
PL (1) | PL361053A1 (en) |
SK (1) | SK4772003A3 (en) |
WO (1) | WO2002032377A2 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030225132A1 (en) * | 2002-04-11 | 2003-12-04 | Dininno Frank P. | Estrogen receptor modulators |
ATE481397T1 (en) * | 2002-04-24 | 2010-10-15 | Merck Sharp & Dohme | MODULATORS OF THE ESTROGEN RECEPTOR |
WO2004058682A1 (en) * | 2002-12-26 | 2004-07-15 | Eisai Co., Ltd. | Selective estrogen receptor modulators |
NZ566180A (en) | 2005-07-29 | 2011-04-29 | Resverlogix Corp | Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices |
US8163770B2 (en) * | 2005-10-27 | 2012-04-24 | Msd. K. K. | Benzoxathiin derivative |
US8053440B2 (en) | 2007-02-01 | 2011-11-08 | Resverlogix Corporation | Compounds for the prevention and treatment of cardiovascular diseases |
AU2010204106B2 (en) | 2009-01-08 | 2014-05-08 | Resverlogix Corp. | Compounds for the prevention and treatment of cardiovascular disease |
NZ617779A (en) | 2009-03-18 | 2015-08-28 | Resverlogix Corp | Novel anti-inflammatory agents |
KR20180096823A (en) | 2009-04-22 | 2018-08-29 | 리스버로직스 코퍼레이션 | Novel anti-inflammatory agents |
LT2580210T (en) | 2010-06-10 | 2017-07-25 | Seragon Pharmaceuticals, Inc. | Estrogen receptor modulators and uses thereof |
WO2011159769A2 (en) | 2010-06-17 | 2011-12-22 | Aragon Pharmaceuticals, Inc. | Indane estrogen receptor modulators and uses thereof |
RS58911B1 (en) | 2011-11-01 | 2019-08-30 | Resverlogix Corp | Oral immediate release formulations for substituted quinazolinones |
JP2015500346A (en) | 2011-12-14 | 2015-01-05 | セラゴン ファーマシューティカルズ,インク. | Estrogen receptor modulators and uses thereof |
US9765039B2 (en) | 2012-11-21 | 2017-09-19 | Zenith Epigenetics Ltd. | Biaryl derivatives as bromodomain inhibitors |
US9073878B2 (en) | 2012-11-21 | 2015-07-07 | Zenith Epigenetics Corp. | Cyclic amines as bromodomain inhibitors |
JP2016507496A (en) | 2012-12-21 | 2016-03-10 | ゼニス・エピジェネティクス・コーポレイションZenith Epigenetics Corp. | Novel heterocyclic compounds as bromodomain inhibitors |
US10111885B2 (en) | 2015-03-13 | 2018-10-30 | Resverlogix Corp. | Compositions and therapeutic methods for the treatment of complement-associated diseases |
-
2001
- 2001-10-15 EP EP01987654A patent/EP1333827A2/en not_active Withdrawn
- 2001-10-15 EA EA200300474A patent/EA200300474A1/en unknown
- 2001-10-15 IL IL15498401A patent/IL154984A0/en unknown
- 2001-10-15 JP JP2002535616A patent/JP2004511502A/en not_active Withdrawn
- 2001-10-15 KR KR10-2003-7005518A patent/KR20030042020A/en not_active Application Discontinuation
- 2001-10-15 AU AU2002232381A patent/AU2002232381B2/en not_active Ceased
- 2001-10-15 WO PCT/US2001/042735 patent/WO2002032377A2/en not_active Application Discontinuation
- 2001-10-15 CN CNA018176720A patent/CN1469743A/en active Pending
- 2001-10-15 CA CA002424729A patent/CA2424729A1/en not_active Abandoned
- 2001-10-15 MX MXPA03003485A patent/MXPA03003485A/en unknown
- 2001-10-15 AU AU3238102A patent/AU3238102A/en active Pending
- 2001-10-15 HU HU0303563A patent/HUP0303563A2/en unknown
- 2001-10-15 PL PL01361053A patent/PL361053A1/en not_active Application Discontinuation
- 2001-10-15 BR BR0114689-0A patent/BR0114689A/en not_active Application Discontinuation
- 2001-10-15 SK SK477-2003A patent/SK4772003A3/en unknown
- 2001-10-15 EE EEP200300153A patent/EE200300153A/en unknown
-
2002
- 2002-04-15 PE PE2002000308A patent/PE20021083A1/en not_active Application Discontinuation
-
2003
- 2003-03-26 BG BG107676A patent/BG107676A/en unknown
- 2003-03-27 IS IS6761A patent/IS6761A/en unknown
- 2003-04-15 NO NO20031737A patent/NO20031737L/en unknown
- 2003-04-17 EC EC2003004558A patent/ECSP034558A/en unknown
Non-Patent Citations (1)
Title |
---|
BENDINSKAS ET AL.: "Sequence-specific photomodification of DNA by an oligonucleotide-phenanthrodihydrodioxin conjugate", BIOCONJUGATE CHEMISTRY, vol. 9, no. 5, September 1998 (1998-09-01), pages 555 - 563, XP002909731 * |
Also Published As
Publication number | Publication date |
---|---|
CN1469743A (en) | 2004-01-21 |
MXPA03003485A (en) | 2003-07-14 |
JP2004511502A (en) | 2004-04-15 |
ECSP034558A (en) | 2003-06-25 |
EA200300474A1 (en) | 2003-10-30 |
AU2002232381B2 (en) | 2004-11-18 |
AU3238102A (en) | 2002-04-29 |
EE200300153A (en) | 2003-06-16 |
HUP0303563A2 (en) | 2004-03-01 |
WO2002032377A2 (en) | 2002-04-25 |
CA2424729A1 (en) | 2002-04-25 |
NO20031737L (en) | 2003-06-19 |
IS6761A (en) | 2003-03-27 |
IL154984A0 (en) | 2003-10-31 |
PE20021083A1 (en) | 2002-12-16 |
BG107676A (en) | 2003-11-28 |
SK4772003A3 (en) | 2003-08-05 |
PL361053A1 (en) | 2004-09-20 |
NO20031737D0 (en) | 2003-04-15 |
KR20030042020A (en) | 2003-05-27 |
BR0114689A (en) | 2003-07-01 |
EP1333827A2 (en) | 2003-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1257264A4 (en) | Estrogen receptor modulators | |
EP1501819A4 (en) | Estrogen receptor modulators | |
WO2002091993A3 (en) | Estrogen receptor modulators | |
WO2002041835A3 (en) | Estrogen receptor modulators | |
TW200631933A (en) | Estrogen receptor modulators | |
WO2006062876A3 (en) | Estrogen receptor modulators | |
WO2002032377A3 (en) | Estrogen receptor modulators | |
WO2004073612A3 (en) | Estrogen receptor modulators | |
WO2004091488A3 (en) | Estrogen receptor modulators | |
WO2007062230A3 (en) | Nuclear receptor binding agents | |
WO2003016270A3 (en) | Selective estrogen receptor modulators | |
WO2002032373A3 (en) | Estrogen receptor modulators | |
WO2006081152A3 (en) | Estrogen receptor modulators | |
WO2007089291A3 (en) | Estrogen receptor modulators | |
AU2003288644A1 (en) | Mercapto-phenyl-naphthyl-methane derivatives and preparation thereof | |
WO2002058639A3 (en) | Pyranoflavonoid compounds and their use as estrogen receptor modulators | |
WO2005097141A3 (en) | Estrogen receptor modulators | |
WO2002053522A3 (en) | Novel estrogen receptor ligands and methods i | |
WO2004073610A3 (en) | Estrogen receptor modulators | |
WO2004026887A3 (en) | Estrogen receptor modulators | |
WO2008057309A3 (en) | Estrogen receptor modulators | |
AR039282A1 (en) | STROGEN RECEIVERS MODULATORS | |
WO2009059806A3 (en) | Preparation of 6-oxa-8alpha-steroid estrogen analogues - a new group of unnatural estrogens and their use in medicine | |
DOP2002000384A (en) | MODULATORS OF ESTROGEN RECEPTORS. | |
DOP2005000224A (en) | MODULATORS OF STROGEN RECEIVERS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 154984 Country of ref document: IL |
|
ENP | Entry into the national phase |
Ref document number: 10767601 Country of ref document: BG Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 524957 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200302501 Country of ref document: ZA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1200300312 Country of ref document: VN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002232381 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2424729 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: P-280/03 Country of ref document: YU |
|
WWE | Wipo information: entry into national phase |
Ref document number: P20030283A Country of ref document: HR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1-2003-500271 Country of ref document: PH |
|
WWE | Wipo information: entry into national phase |
Ref document number: 4772003 Country of ref document: SK Ref document number: PA/a/2003/003485 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: PV2003-1089 Country of ref document: CZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002535616 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020037005518 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 018176720 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001987654 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 735/CHENP/2003 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200300474 Country of ref document: EA |
|
ENP | Entry into the national phase |
Ref document number: 20030789 Country of ref document: UZ Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 5223 Country of ref document: GE |
|
WWP | Wipo information: published in national office |
Ref document number: 1020037005518 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2001987654 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWR | Wipo information: refused in national office |
Ref document number: PV2003-1089 Country of ref document: CZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 2002232381 Country of ref document: AU |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001987654 Country of ref document: EP |